中药干预骨髓干细胞治疗缺血性心脏病研究进展  

Research Progress of the Interference of Traditional Chinese Medicine on Myeloid Stem Cells Therapy for Ischemic Heart Disease

作　　者：李慧影[1] 马亚珂 杨岳[1] 王虹[1] 

机构地区：[1]天津中医药大学,天津300193

出　　处：《湖北中医药大学学报》2015年第6期107-109,共3页Journal of Hubei University of Chinese Medicine

基　　金：国家自然科学基金(面上项目)(81173592);新世纪优秀人才支持计划(NCET-13-0935);长江学者和创新团队发展计划资助(IRT0973)

摘　　要：近年来细胞治疗技术利用骨髓干细胞介导血管及心肌的再生,为缺血性心脏病的治疗带来了新的前景,中医药对干细胞的作用成为研究的热点,现针对几味中药干预骨髓干细胞治疗缺血性心脏病的研究进展作一综述。In recent years,the use of bone marrow stem cell mediated regeneration of vascular and cardiac in cell therapyhas brought a new prospect for the treatment of ischemic heart disease,and the role of traditional Chinese medicine on stem cells has become the hot spot of research. This paper reviewed the researches on the interference of some traditional Chinese medicine on bone marrow stem cell to cure ischemic heart disease.

关 键 词：骨髓干细胞 缺血性心脏病 中药 

分 类 号：R259[医药卫生—中西医结合] R28[医药卫生—中医内科学]